NRIX
Nurix Therapeutics, Inc. Common stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Nurix Therapeutics (NRIX) Stock: Buy, Sell, or Hold?
$16.06
+0.17 (+1.10%)
▲
5d:
+0.66%
30d:
-27.45%
90d:
-40.95%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
46/100
Position
OVERSOLD
30-Day Fair Range
$19.21 – $26.79
Position: OVERSOLD
Forward P/E & Valuation
-12.5x
Next 12M consensus est.
Wall Street Target
$33.50
+111.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$14.78 / $27.99
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NRIX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When NRIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NRIX is currently trading at $16.05, which is considered oversold relative to its 30-day fair value range of $19.21 to $26.79.
Technical Outlook: Technically, NRIX is showing sideways momentum. Immediate support is located at $14.78, while resistance sits at $27.99.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.50 (+111.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRIX is showing sideways momentum. Immediate support is located at $14.78, while resistance sits at $27.99.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.50 (+111.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.21 -
$26.79
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$19.21 -
$26.79
Current vs Trading Range
OVERSOLD
Support Level
$14.78
Resistance Level
$27.99
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 111.0% below Wall St target ($33.50)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-12.45
Wall Street Target
$33.50
(+111.0%)
Revenue Growth (YoY)
8426.3%
Profit Margin
42.0%
Share NRIX Analysis
Share this live NRIX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NRIX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
One bullish trader on StockTwits expressed optimism and announced a long position on $NRIX.
Key Retail Themes:
Bullish sentiment
Long position
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:22 AM ET
Data refreshes hourly during market hours. Next update: 10:22 AM
Data refreshes hourly during market hours. Next update: 10:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 46 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NRIX Research Pages
